Thus, a dual-targeted peptide was synthesised, in which a HER2-specific sequence (LTVSPWYLTVSPWY) was linked to an SR-BI-specific sequence (FAEKFKEAVKDYFAKFWD) via a GSG linker, demonstrating its superior specificity in NPC xenograft tumours [16]. The gene discussed is ERBB2; the disease is neoplasm.